136 related articles for article (PubMed ID: 31078809)
1. Recurrent Papillary Glioneuronal Tumor.
Goethe EA; Youssef M; Patel AJ; Jalali A; Goodman JC; Mandel JJ
World Neurosurg; 2019 Aug; 128():127-130. PubMed ID: 31078809
[TBL] [Abstract][Full Text] [Related]
2. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
[TBL] [Abstract][Full Text] [Related]
3. Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases.
Ballester LY; Moghadamtousi SZ; Leeds NE; Huse JT; Fuller GN
Acta Neuropathol Commun; 2019 Apr; 7(1):63. PubMed ID: 31036092
[No Abstract] [Full Text] [Related]
4. Papillary glioneuronal tumor: unexplored entity.
Lavrnic S; Macvanski M; Ristic-Balos D; Gavrilov M; Damjanovic D; Gavrilovic S; Milicevic M; Skender-Gazibara M; Stosic-Opincal T
J Neurol Surg A Cent Eur Neurosurg; 2012 Aug; 73(4):224-9. PubMed ID: 21842459
[TBL] [Abstract][Full Text] [Related]
5. Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.
Bielle F; Di Stefano AL; Meyronet D; Picca A; Villa C; Bernier M; Schmitt Y; Giry M; Rousseau A; Figarella-Branger D; Maurage CA; Uro-Coste E; Lasorella A; Iavarone A; Sanson M; Mokhtari K
Brain Pathol; 2018 Sep; 28(5):674-683. PubMed ID: 28976058
[TBL] [Abstract][Full Text] [Related]
6. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.
Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T
World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247
[TBL] [Abstract][Full Text] [Related]
7. Aggressive papillary glioneuronal tumor: case report and literature review.
Newton HB; Dalton J; Ray-Chaudhury A; Gahbauer R; McGregor J
Clin Neuropathol; 2008; 27(5):317-24. PubMed ID: 18808063
[TBL] [Abstract][Full Text] [Related]
8. Clinical, radiological, and pathological features of 16 papillary glioneuronal tumors.
Li D; Wang JM; Li GL; Hao SY; Yang Y; Wu Z; Zhang LW; Zhang JT
Acta Neurochir (Wien); 2014 Apr; 156(4):627-39. PubMed ID: 24553727
[TBL] [Abstract][Full Text] [Related]
9. [Computed tomographic features of cerebral malignant glioma following treatment and regrowth. Growth patterns of recurrent tumors].
Sato I; Tanaka R; Takeda N; Suzuki Y; Hondo H
Neurol Med Chir (Tokyo); 1988 Nov; 28(11):1073-80. PubMed ID: 2466210
[No Abstract] [Full Text] [Related]
10. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.
Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
[TBL] [Abstract][Full Text] [Related]
11. Papillary glioneuronal tumors: a review of clinicopathologic and molecular genetic studies.
Myung JK; Byeon SJ; Kim B; Suh J; Kim SK; Park CK; Chung CK; Chang KH; Park SH
Am J Surg Pathol; 2011 Dec; 35(12):1794-805. PubMed ID: 22020040
[TBL] [Abstract][Full Text] [Related]
12. Papillary glioneuronal tumor. A case report.
Castro Castro J; Lista Martínez O; Caramés Díaz N; Conde Lorenzo N
Neurocirugia (Astur : Engl Ed); 2019; 30(3):144-148. PubMed ID: 29789203
[TBL] [Abstract][Full Text] [Related]
13. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
[TBL] [Abstract][Full Text] [Related]
14. Glioneuronal tumors of cerebral hemisphere in children: correlation of surgical resection with seizure outcomes and tumor recurrences.
Tomita T; Volk JM; Shen W; Pundy T
Childs Nerv Syst; 2016 Oct; 32(10):1839-48. PubMed ID: 27659827
[TBL] [Abstract][Full Text] [Related]
15. Papillary glioneuronal tumor with a high proliferative component and minigemistocytes in a child.
Momota H; Fujii M; Tatematsu A; Shimoyama Y; Tsujiuchi T; Ohno M; Natsume A; Wakabayashi T
Neuropathology; 2014 Oct; 34(5):484-90. PubMed ID: 24738632
[TBL] [Abstract][Full Text] [Related]
16. Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature.
Kumar A A; Abraham Koshy A
World Neurosurg; 2017 Dec; 108():990.e11-990.e16. PubMed ID: 28867318
[TBL] [Abstract][Full Text] [Related]
17. Papillary glioneuronal tumor growing slowly for 26 years: illustrative case.
Shinno K; Arakawa Y; Minamiguchi S; Terada Y; Tanji M; Mineharu Y; Kikuchi T; Haga H; Miyamoto S
J Neurosurg Case Lessons; 2021 Jul; 2(1):CASE21266. PubMed ID: 35854961
[TBL] [Abstract][Full Text] [Related]
18. Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System.
Weinberg BD; Gore A; Shu HG; Olson JJ; Duszak R; Voloschin AD; Hoch MJ
J Am Coll Radiol; 2018 May; 15(5):767-771. PubMed ID: 29503151
[No Abstract] [Full Text] [Related]
19. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
[TBL] [Abstract][Full Text] [Related]
20. Papillary glioneuronal tumor: case report and review of literature.
Carangelo B; Arrigucci U; Mariottini A; Lavalle L; Muscas G; Branco D; Lippa L; Peri G; Muya M; Costantino G; Tiezzi G; Tacchini D; Maturo A
G Chir; 2015; 36(2):63-9. PubMed ID: 26017104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
